Bioventus (BVS) Income from Non-Controlling Interests (2020 - 2026)
Bioventus posted quarterly Income from Non-Controlling Interests of $833000.0 for Q1 2026, up 221.61% year-on-year from $259012.7 in Q1 2025, and down 67.5% on a QoQ basis from $2.6 million in Q4 2025.
Bioventus (BVS) has 7 years of Income from Non-Controlling Interests data on file, last reported at $833000.0 in Q1 2026.
- For the quarter ending Q1 2026, Income from Non-Controlling Interests rose 221.61% year-over-year to $833000.0; the trailing twelve-month figure through Mar 2026 stood at $6.1 million (up 651.86% YoY), and the FY2025 full-year result was $4.5 million, changed N/A from the prior year.
- Income from Non-Controlling Interests for Q1 2026 stood at $833000.0, down from $2.6 million in the prior quarter.
- Across five years, Income from Non-Controlling Interests topped out at $18.5 million in Q4 2022 and bottomed at -$20.4 million in Q2 2023.
- The 5-year median for Income from Non-Controlling Interests is -$685000.0 (2025), against an average of -$765133.3.
- Peak annual rise in Income from Non-Controlling Interests reached 1312.43% in 2022, while the deepest fall reached 764.95% in 2022.
- A 5-year view of Income from Non-Controlling Interests shows it stood at $18.5 million in 2022, then slumped by 108.03% to -$1.5 million in 2023, then soared by 819.69% to $10.7 million in 2024, then tumbled by 76.07% to $2.6 million in 2025, then sank by 67.5% to $833000.0 in 2026.
- The last three Income from Non-Controlling Interests figures came in at $833000.0 (Q1 2026), $2.6 million (Q4 2025), and $851000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | - |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | - |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 6.00 Mn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -2.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -5.85 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 22.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 100,000.00 |
| 10 | Bioventus | 535.01 Mn | 544.52 Mn | 90.77 Mn | 833,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 28, 2026 | 833,000.00 |
| Dec 31, 2025 | 2.56 Mn |
| Sep 27, 2025 | 851,000.00 |
| Jun 28, 2025 | 1.81 Mn |
| Mar 29, 2025 | -685,000.00 |
| Dec 31, 2024 | 10.71 Mn |
| Sep 28, 2024 | -683,000.00 |
| Jun 29, 2024 | -8.54 Mn |
| Mar 30, 2024 | -1.49 Mn |
| Sep 30, 2023 | -1.49 Mn |
| Apr 1, 2023 | -20.36 Mn |
| Dec 31, 2022 | 18.54 Mn |
| Oct 1, 2022 | -9.25 Mn |
| Jul 2, 2022 | -762,000.00 |
| Apr 2, 2022 | -3.53 Mn |
| Dec 31, 2021 | -1.53 Mn |
| Oct 2, 2021 | -1.30 Mn |
| Jul 3, 2021 | -6.65 Mn |
| Apr 3, 2021 | -408,000.00 |
| Dec 31, 2020 | -525,000.00 |
| Sep 26, 2020 | -492,000.00 |
| Jun 27, 2020 | -214,000.00 |
| Mar 28, 2020 | -458,000.00 |